|
2025-04-11 |
2025-04-09 |
B
Purchase
|
ADAR1 Capital Management, LLC
Large shareholder
|
1,000
+1.7%
10.33
USD 767,860
|
1,000
+1.7%
|
10.33
|
USD 100,000
|
|
|
2025-04-11 |
2025-04-09 |
B
Purchase
|
ADAR1 Capital Management, LLC
Large shareholder
|
1,000
+13.1%
10.33
USD 5,165,000
|
1,000
+13.1%
|
10.33
|
USD 100,000
|
|
|
2025-04-11 |
2025-04-09 |
B
Purchase
|
ADAR1 Capital Management, LLC
Large shareholder
|
1,000
+9.3%
9.86
USD 3,203,525
|
1,000
+9.3%
|
9.86
|
USD 100,000
|
|
|
2025-04-11 |
2025-04-09 |
B
Purchase
|
ADAR1 Capital Management, LLC
Large shareholder
|
1,000
+2.3%
9.40
USD 153,752
|
1,000
+2.3%
|
9.40
|
USD 100,000
|
|
|
2025-04-11 |
2025-04-09 |
B
Purchase
|
ADAR1 Capital Management, LLC
Large shareholder
|
1,000
+0.5%
9.40
USD 174,375
|
1,000
+0.5%
|
9.40
|
USD 100,000
|
|
|
2024-08-15 |
2024-08-13 |
S
Sale
|
GORDON CARL L
Non-Executive Director
|
29,400
-19.7%
44.01
USD 1,293,894
|
29,400
-19.7%
|
44.01
|
USD 1,293,894
|
|
|
2024-08-15 |
2024-08-13 |
S
Sale
|
GORDON CARL L
Non-Executive Director
|
220,600
-19.7%
44.01
USD 9,708,606
|
220,600
-19.7%
|
44.01
|
USD 9,708,606
|
|
|
2024-08-15 |
2024-08-13 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
29,400
-19.7%
44.01
USD 1,293,894
|
29,400
-19.7%
|
44.01
|
USD 1,293,894
|
|
|
2024-08-15 |
2024-08-13 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
220,600
-19.7%
44.01
USD 9,708,606
|
220,600
-19.7%
|
44.01
|
USD 9,708,606
|
|
|
2024-01-08 |
2023-11-04 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
40,000
-100.0%
45.29
USD 1,811,600
|
40,000
-100.0%
|
45.29
|
USD 1,811,600
|
|
|
2023-06-12 |
2023-06-09 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
2,579
-100.0%
47.25
USD 121,858
|
2,579
-100.0%
|
47.25
|
USD 121,858
|
|
|
2023-06-12 |
2023-06-09 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
1,428
-35.6%
46.46
USD 66,345
|
1,428
-35.6%
|
46.46
|
USD 66,345
|
|
|
2023-06-12 |
2023-06-09 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
15,993
-80.0%
45.03
USD 720,165
|
15,993
-80.0%
|
45.03
|
USD 720,165
|
|
|
2023-06-12 |
2023-06-08 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
2,699
-100.0%
48.65
USD 131,306
|
2,699
-100.0%
|
48.65
|
USD 131,306
|
|
|
2023-06-12 |
2023-06-08 |
PS
Planned sale
|
Regnante Keith
Chief Financial Officer
Officer
|
17,301
-86.5%
47.66
USD 824,566
|
17,301
-86.5%
|
47.66
|
USD 824,566
|
|
|
2022-07-19 |
2022-07-15 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
46,034
-32.6%
30.00
USD 1,381,020
|
46,034
-32.6%
|
30.00
|
USD 1,381,020
|
|
|
2022-07-15 |
2022-07-13 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,916
-2.0%
30.00
USD 57,480
|
1,916
-2.0%
|
30.00
|
USD 57,480
|
|
|
2022-05-13 |
2022-05-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
16
-0.0%
45.45
USD 727
|
16
-0.0%
|
45.45
|
USD 727
|
|
|
2022-05-13 |
2022-05-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
223
-0.3%
44.23
USD 9,863
|
223
-0.3%
|
44.23
|
USD 9,863
|
|
|
2022-05-13 |
2022-05-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
719
-0.8%
43.32
USD 31,147
|
719
-0.8%
|
43.32
|
USD 31,147
|
|
|
2022-05-13 |
2022-05-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
944
-1.1%
42.49
USD 40,111
|
944
-1.1%
|
42.49
|
USD 40,111
|
|
|
2022-05-13 |
2022-05-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
3,398
-3.7%
41.26
USD 140,201
|
3,398
-3.7%
|
41.26
|
USD 140,201
|
|
|
2022-04-13 |
2022-04-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
559
-0.6%
64.15
USD 35,860
|
559
-0.6%
|
64.15
|
USD 35,860
|
|
|
2022-04-13 |
2022-04-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
2,315
-2.6%
63.50
USD 147,003
|
2,315
-2.6%
|
63.50
|
USD 147,003
|
|
|
2022-04-13 |
2022-04-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,009
-1.1%
62.32
USD 62,881
|
1,009
-1.1%
|
62.32
|
USD 62,881
|
|
|
2022-04-13 |
2022-04-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,417
-1.6%
61.37
USD 86,961
|
1,417
-1.6%
|
61.37
|
USD 86,961
|
|
|
2022-04-08 |
2022-04-06 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
1,728
-100.0%
65.00
USD 112,320
|
1,728
-100.0%
|
65.00
|
USD 112,320
|
|
|
2022-04-06 |
2022-04-04 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
7,950
-8.5%
60.00
USD 477,000
|
7,950
-8.5%
|
60.00
|
USD 477,000
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
105
-100.0%
58.83
USD 6,177
|
105
-100.0%
|
58.83
|
USD 6,177
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
366
-77.7%
57.97
USD 21,217
|
366
-77.7%
|
57.97
|
USD 21,217
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
287
-37.9%
56.89
USD 16,327
|
287
-37.9%
|
56.89
|
USD 16,327
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
104
-12.1%
56.20
USD 5,845
|
104
-12.1%
|
56.20
|
USD 5,845
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Rovaldi Christopher
Chief Operating Officer
Officer
|
2
-0.2%
54.34
USD 109
|
2
-0.2%
|
54.34
|
USD 109
|
|
|
2022-03-15 |
2022-03-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
875
-1.0%
54.54
USD 47,723
|
875
-1.0%
|
54.54
|
USD 47,723
|
|
|
2022-03-15 |
2022-03-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
713
-0.8%
53.36
USD 38,046
|
713
-0.8%
|
53.36
|
USD 38,046
|
|
|
2022-03-15 |
2022-03-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,062
-1.2%
52.43
USD 55,681
|
1,062
-1.2%
|
52.43
|
USD 55,681
|
|
|
2022-02-15 |
2022-02-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
199
-0.2%
53.10
USD 10,567
|
199
-0.2%
|
53.10
|
USD 10,567
|
|
|
2022-02-15 |
2022-02-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,378
-1.6%
52.35
USD 72,138
|
1,378
-1.6%
|
52.35
|
USD 72,138
|
|
|
2022-02-15 |
2022-02-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,073
-1.2%
51.50
USD 55,260
|
1,073
-1.2%
|
51.50
|
USD 55,260
|
|
|
2022-01-13 |
2022-01-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,134
-1.3%
54.45
USD 61,746
|
1,134
-1.3%
|
54.45
|
USD 61,746
|
|
|
2022-01-13 |
2022-01-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,196
-1.4%
53.56
USD 64,058
|
1,196
-1.4%
|
53.56
|
USD 64,058
|
|
|
2022-01-13 |
2022-01-11 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
320
-0.4%
52.01
USD 16,643
|
320
-0.4%
|
52.01
|
USD 16,643
|
|
|
2022-01-07 |
2022-01-05 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
2,650
-3.0%
60.00
USD 159,000
|
2,650
-3.0%
|
60.00
|
USD 159,000
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
435
-0.2%
59.00
USD 25,665
|
435
-0.2%
|
59.00
|
USD 25,665
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
667
-0.2%
59.00
USD 39,353
|
667
-0.2%
|
59.00
|
USD 39,353
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
886
-0.4%
58.20
USD 51,565
|
886
-0.4%
|
58.20
|
USD 51,565
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
1,356
-0.4%
58.20
USD 78,919
|
1,356
-0.4%
|
58.20
|
USD 78,919
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
271
-0.1%
57.23
USD 15,509
|
271
-0.1%
|
57.23
|
USD 15,509
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
419
-0.1%
57.23
USD 23,979
|
419
-0.1%
|
57.23
|
USD 23,979
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
2,195
-0.9%
58.86
USD 129,198
|
2,195
-0.9%
|
58.86
|
USD 129,198
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
3,367
-1.0%
58.86
USD 198,182
|
3,367
-1.0%
|
58.86
|
USD 198,182
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
2,704
-1.1%
57.99
USD 156,805
|
2,704
-1.1%
|
57.99
|
USD 156,805
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
4,151
-1.2%
57.99
USD 240,716
|
4,151
-1.2%
|
57.99
|
USD 240,716
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
1,113
-0.5%
56.95
USD 63,385
|
1,113
-0.5%
|
56.95
|
USD 63,385
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
1,707
-0.5%
56.95
USD 97,214
|
1,707
-0.5%
|
56.95
|
USD 97,214
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
1,383
-0.6%
56.10
USD 77,586
|
1,383
-0.6%
|
56.10
|
USD 77,586
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
2,124
-0.6%
56.10
USD 119,156
|
2,124
-0.6%
|
56.10
|
USD 119,156
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
524
-0.2%
54.95
USD 28,794
|
524
-0.2%
|
54.95
|
USD 28,794
|
|
|
2022-01-05 |
2022-01-04 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
794
-0.2%
54.95
USD 43,630
|
794
-0.2%
|
54.95
|
USD 43,630
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
162
-0.1%
59.40
USD 9,623
|
162
-0.1%
|
59.40
|
USD 9,623
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
249
-0.1%
59.40
USD 14,791
|
249
-0.1%
|
59.40
|
USD 14,791
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
3,412
-1.4%
58.96
USD 201,172
|
3,412
-1.4%
|
58.96
|
USD 201,172
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
5,236
-1.4%
58.96
USD 308,715
|
5,236
-1.4%
|
58.96
|
USD 308,715
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
3,318
-1.3%
57.83
USD 191,880
|
3,318
-1.3%
|
57.83
|
USD 191,880
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
5,094
-1.4%
57.83
USD 294,586
|
5,094
-1.4%
|
57.83
|
USD 294,586
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
2,406
-1.0%
56.82
USD 136,709
|
2,406
-1.0%
|
56.82
|
USD 136,709
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
3,678
-1.0%
56.82
USD 208,984
|
3,678
-1.0%
|
56.82
|
USD 208,984
|
|
|
2021-12-15 |
2021-12-15 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
735
-0.9%
50.00
USD 36,750
|
735
-0.9%
|
50.00
|
USD 36,750
|
|
|
2021-12-15 |
2021-12-13 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
7
-0.0%
53.64
USD 375
|
7
-0.0%
|
53.64
|
USD 375
|
|
|
2021-12-15 |
2021-12-13 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
390
-0.5%
52.22
USD 20,366
|
390
-0.5%
|
52.22
|
USD 20,366
|
|
|
2021-12-15 |
2021-12-13 |
PS
Planned sale
|
Lachey Jennifer
Chief Scientific Officer
Officer
|
1,518
-1.7%
50.11
USD 76,067
|
1,518
-1.7%
|
50.11
|
USD 76,067
|
|
|
2021-12-03 |
2021-12-02 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
90
-0.0%
54.67
USD 4,920
|
90
-0.0%
|
54.67
|
USD 4,920
|
|
|
2021-12-03 |
2021-12-02 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
138
-0.0%
54.67
USD 7,544
|
138
-0.0%
|
54.67
|
USD 7,544
|
|
|
2021-12-03 |
2021-12-02 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
5,705
-2.2%
53.86
USD 307,271
|
5,705
-2.2%
|
53.86
|
USD 307,271
|
|
|
2021-12-03 |
2021-12-02 |
PS
Planned sale
|
Knowles Julius
Non-Executive Director
|
8,747
-2.3%
53.86
USD 471,113
|
8,747
-2.3%
|
53.86
|
USD 471,113
|
|
